Skip to content

Author

Tariq Aziz

We have 4 of 24 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Design, synthesis, and biological evaluation of pyrimidine linked fused thiazole–isoxazole conjugates as dual cholinesterase inhibitors for Alzheimer’s disease

Abstract Alzheimer’s disease (AD) affects over 55 million individuals worldwide, yet approved pharmacotherapies remain limited to symptomatic relief. Dual inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) offers a validated approach to restoring cholinergic tone. However, structurally differen...

Y. Khan, Mujeeb Ul Naeem, Syeda Farwa Naqvi et al. · 0 citations
Open access Oct 2026

Integrated Transcriptomic and Network Analysis Identifies Diagnostic and Immune-Associated Hub Genes in Urothelial Carcinoma

Background: Urothelial carcinoma exhibits molecular heterogeneity, high recurrence, and progression rates, and is poorly diagnosed and treated. Transcriptomic and systems-biology analyses can detect dysregulated genes, signaling pathways, and interactions of immune cells. Proposed biomarkers, however, have not been val...

Shaza N. Alkhatib, A. Binsaleh, N. Al-Hoshani et al. · 0 citations
Open access Aug 2026

Structure-Guided Immunoinformatics for the Rational Design of a Multi-Epitope Vaccine Against Batai Orthobunyavirus

This study presents a structurally optimized and validated multiepitope vaccine candidate against the emerging Batai orthobunyavirus, identifying a promising vaccine candidate for further investigation; however, its immunogenicity, safety, and protective efficacy before further vaccine development can be considered.

M. A. Alwaili, N. Al‐Hoshani, Huda A Alqahtani et al. · 0 citations
Open access Jul 2026

Integrative immunoinformatics and structural modeling for the rational design of a multi-epitope vaccine candidate against human cytomegalovirus

The results highlight the potential of the proposed multi-epitope construct as a promising vaccine candidate against HCMV, however, experimental validation is essential to confirm its immunogenicity, safety, and translational applicability.

O. P. Emmanuel, M. N. Y. Sandrine, Bilanda Danielle Claude et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.